References
1. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the
diagnosis and management of atrial fibrillation developed in
collaboration with the European Association of Cardio-Thoracic Surgery
(EACTS). Eur Heart J. 2020;ehaa612.
2. Calkins H, Hindricks G, Cappato R, et al. 2017
HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and
surgical ablation of atrial fibrillation. Heart Rhythm.2017;14(10):e275-e444.
3. Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation
for persistent atrial fibrillation. N Engl J Med.2015;372(19):1812-22.
4. Kirchhof P, Calkins H. Catheter ablation in patients with persistent
atrial fibrillation. Eur Heart J. 2017;38(1):20-26.
5. Gianni C, Mohanty S, Trivedi C, et al. Novel concepts and approaches
in ablation of atrial fibrillation: the role of non-pulmonary vein
triggers. Europace. 2018;20(10):1566-1576.
6. van Campenhout MJ, Yaksh A, Kik C, et al. Bachmann’s bundle: a key
player in the development of atrial fibrillation? Circ Arrhythm
Electrophysiol. 2013;6(5):1041-6.
7. Rodríguez-Mañero M, Schurmann P, Valderrábano M. Ligament and vein of
Marshall: A therapeutic opportunity in atrial fibrillation. Heart
Rhythm. 2016;13(2):593-601.
8. Della Bella P, Brugada J, Zeppenfeld K, et al. Epicardial ablation
for ventricular tachycardia: a European multicenter study. Circ
Arrhythm Electrophysiol. 2011;4(5):653-9.
9. Piorkowski C, Kronborg M, Hourdain J, et al. Endo-/Epicardial
Catheter Ablation of Atrial Fibrillation: Feasibility, Outcome, and
Insights Into Arrhythmia Mechanisms. Circ Arrhythm
Electrophysiol. 2018;11(2):e005748.
10. Jiang R, Buch E, Gima J, et al. Feasibility of percutaneous
epicardial mapping and ablation for refractory atrial fibrillation:
Insights into substrate and lesion transmurality. Heart Rhythm.2019;16(8):1151-1159.
11. Yu L, Liu Q, Jiang RH, et al. Adjunctive percutaneous ablation
targeting epicardial arrhythmogenic structures in patients of atrial
fibrillation with recurrence after multiple procedures. J
Cardiovasc Electrophysiol. 2020;31(2):401-409.
12. Hussein A, Das M, Riva S, et al. Use of Ablation Index-Guided
Ablation Results in High Rates of Durable Pulmonary Vein Isolation and
Freedom From Arrhythmia in Persistent Atrial Fibrillation Patients: The
PRAISE Study Results. Circ Arrhythm Electrophysiol.2018;11(9):e006576.
13. Sosa E, Scanavacca M, d’Avila A, et al. A new technique to perform
epicardial mapping in the electrophysiology laboratory. J
Cardiovasc Electrophysiol. 1996;7(6):531-6.
14. Shah D, Haïssaguerre M, Takahashi A, et al. Differential pacing for
distinguishing block from persistent conduction through an ablation
line. Circulation. 2000;102(13):1517-22.
15. Lachman N, Syed FF, Habib A, et al. Correlative anatomy for the
electrophysiologist, Part I: the pericardial space, oblique sinus,
transverse sinus. J Cardiovasc Electrophysiol.2010;21(12):1421-6.
16. de Groot N, van der Does L, Yaksh A, et al. Direct Proof of
Endo-Epicardial Asynchrony of the Atrial Wall During Atrial Fibrillation
in Humans. Circ Arrhythm Electrophysiol. 2016;9(5):e003648.
17. Bayés de Luna A, Cladellas M, Oter R, et al. Interatrial conduction
block and retrograde activation of the left atrium and paroxysmal
supraventricular tachyarrhythmia. Eur Heart J. 1988;9(10):1112-8.
18. Moser F, Rieger A, Pönisch C, et al. A novel ablation approach in
atrial fibrillation patients undergoing fibrotic-based substrate
modification: Targeting the Bachmann’s bundle? J Cardiovasc
Electrophysiol. 2018;29(6):844-853.
19. Zhang J, Tang C, Zhang Y, et al. Electrophysiologic and Clinical
Consequences of Left Atrial Anterior Wall Linear Ablation in Patients
With Persistent Atrial Fibrillation. J Cardiovasc Electrophysiol.2015;26(9):934-943.
20. Rillig A, Tilz RR, Lin T, et al. Unexpectedly High Incidence of
Stroke and Left Atrial Appendage Thrombus Formation After Electrical
Isolation of the Left Atrial Appendage for the Treatment of Atrial
Tachyarrhythmias. Circ Arrhythm Electrophysiol.2016;9(5):e003461.
21. Glikson M, Wolff R, Hindricks G, et al. EHRA/EAPCI expert consensus
statement on catheter-based left atrial appendage occlusion - an update.Europace. 2019:euz258.
22. Lim HS, Derval N, Komatsu Y, et al. Is ablation to termination the
best strategy for ablation of persistent atrial fibrillation? Persistent
atrial fibrillation is best ablated by a strategy that terminates the
arrhythmia: procedural termination is associated with improved long-term
outcomes. Circ Arrhythm Electrophysiol. 2015;8(4):963-71.
23. Scherr D, Khairy P, Miyazaki S, et al. Five-year outcome of catheter
ablation of persistent atrial fibrillation using termination of atrial
fibrillation as a procedural endpoint. Circ Arrhythm
Electrophysiol. 2015;8(1):18-24.
24. Khoynezhad A, Ellenbogen KA, Al-Atassi T, et al. Hybrid Atrial
Fibrillation Ablation: Current Status and a Look Ahead. Circ
Arrhythm Electrophysiol. 2017;10(10):e005263.
25. DeLurgio DB, Crossen KJ, Gill J, et al. Hybrid Convergent Procedure
for the Treatment of Persistent and Long Standing Persistent Atrial
Fibrillation: Results of CONVERGE Clinical Trial. Circ Arrhythm
Electrophysiol. 2020. doi: 10.1161/CIRCEP.120.009288.
26. Zimetbaum P. Antiarrhythmic drug therapy for atrial fibrillation.Circulation. 2012;125(2):381-9.
27. Di Biase L, Mohanty P, Mohanty S, et al. Ablation Versus Amiodarone
for Treatment of Persistent Atrial Fibrillation in Patients With
Congestive Heart Failure and an Implanted Device: Results From the AATAC
Multicenter Randomized Trial. Circulation. 2016;133(17):1637-44.